Balanced news tone
News Sentiment
LLY sentiment intelligence
Eli Lilly and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-4.3% over one week, +9.6% over four weeks, trend active, and near fair-value range.
Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 17 Jul 2026 17:04
- Source
- Investor's Business Daily
Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 15:31
- Source
- TradingView
Eli Lilly & Co. (NYSE:LLY) Stands Out With High Growth Momentum and a Breakout Setup
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Jul 2026 12:30
- Source
- ChartMill
Eli Lilly deal to buy AtaiBeckley boosts psychedelic stocks
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 15:32
- Source
- Seeking Alpha
AtaiBeckley jumps 30% as Eli Lilly agrees to buy psychedelic firm for up to $3.8B (LLY:NYSE)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 10:57
- Source
- Seeking Alpha
Eli Lilly (LLY) Stock May Be Below Fair Value After FDA Cancer Drug Approval
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 16 Jul 2026 10:42
- Source
- simplywall.st
How to Buy Eli Lilly Stock (LLY) & Investment Guide
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2026 13:47
- Source
- LiteFinance
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 21:45
- Source
- Market source
Is Lilly Stock On Track To Hit $2,090?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 14:10
- Source
- Forbes
Eli Lilly Stock (LLY) Opinions on Analyst Upgrades and Biotech Momentum
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 13 Jul 2026 17:34
- Source
- Quiver Quantitative
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Why Is Eli Lilly (LLY) Stock Soaring Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jun 2026 14:45
- Source
- AOL.com
Eli Lilly Stock - Analyst consensus stays bullish on weight-loss boom
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 20 Jun 2026 07:00
- Source
- ad-hoc-news.de
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 17:49
- Source
- AOL.com
Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- AOL.com
Is It Too Late To Buy The Rally In Eli Lilly Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Forbes
Eli Lilly oral drug linked to 30.4 lbs loss for women, no food timing rules
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 07 Jun 2026 07:00
- Source
- Stock Titan
Novo Nordisk vs. Eli Lilly: Wegovy Pill Performance and Stock Outlook in 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 06 Jun 2026 07:00
- Source
- IndexBox
Eli Lilly (LLY) Stock Analysis: Diversification Strategy and Vaccine Deals in 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- IndexBox
Eli Lilly & Co. stock (US5324571083): Q1 revenues surge 56% on obesity drug boom
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
Eli Lilly shares surge after strong earnings beat
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Latest news from Azerbaijan
Mizuho's Jared Holz on Eli Lilly's earnings beat and stock reaction
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- MSN
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook
- Tone
- Positive 82/100
- Event
- Guidance
- Published
- 22 Mar 2026 07:00
- Source
- Market source
Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 19 Mar 2026 18:57
- Source
- AOL.com
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Barron's
What Are The Biggest Risks To Eli Lilly Stock?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 05 Mar 2026 08:00
- Source
- Forbes
LLY stock jumps 9%: Why Eli Lilly stock is soaring today - Mounjaro, Zepbound sales drive massive earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Feb 2026 08:00
- Source
- The Economic Times
Eli Lilly Stock Slides Amid Rising Industry Headwinds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Evrim Ağacı
3 Reasons A Pullback In Eli Lilly Stock Is Likely
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Forbes